maganin sabon maganin ciwon huhu na 2020

Sabbin Ciwon Kankara na Huhu: 2020 da Bayan Gaba

Wannan labarin yana ba da bayyani na mahimman ci gaba a ciki maganin sabon maganin ciwon huhu na 2020 kuma bayan haka. Muna bincika mahimman ci gaba a cikin hanyoyin kwantar da hankali, immunotherapies, da sauran sabbin hanyoyin dabarun, suna mai da hankali kan tasirin su da tasirin tasirin haƙuri akan sakamakon haƙuri. Koyi game da sabon bincike da ci gaba da gwaje-gwajen asibiti da ke tsara makomar kula da ciwon huhu.

Magungunan da aka Nufi: Mahimmancin Magani yana ɗaukar matakin tsakiya

Ci gaba a cikin EGFR da ALK Inhibitors

An sami gagarumin ci gaba a cikin hanyoyin kwantar da hankali, musamman ga marasa lafiya da ke da takamaiman maye gurbi. Magani sabon nasarar maganin kansar huhu 2020 ya ga yarda da yawa sabbin masu hana EGFR da ALK, suna ba da ingantacciyar inganci da haƙuri idan aka kwatanta da tsararraki na farko. Waɗannan magungunan suna zaɓaɓɓun ƙwayoyin cutar kansa da waɗannan maye gurbi, suna rage lalacewar kyallen jikin lafiya. Misali, haɓakar masu hana EGFR na ƙarni na uku sun nuna alƙawarin shawo kan juriya ga jiyya na farko. Ƙarin bincike ya ci gaba da gano yiwuwar waɗannan hanyoyin kwantar da hankali tare da sauran jiyya.

Immunotherapies: Yin amfani da Ƙarfin Tsarin rigakafi

Masu hana Kayayyakin Bincike da Matsayin su a Maganin Ciwon Sankara na Huhu

Magungunan rigakafi, waɗanda ke amfani da tsarin rigakafi na jiki don yaƙar ciwon daji, sun sami sauyi maganin sabon maganin ciwon huhu na 2020. Masu hana abubuwan dubawa, irin su PD-1 da PD-L1 masu hanawa, sun nuna gagarumar nasara wajen faɗaɗa rayuwa a cikin marasa lafiya da ke fama da ciwon huhu. Wadannan kwayoyi suna toshe siginar da ƙwayoyin kansa ke amfani da su don guje wa tsarin rigakafi, barin ƙwayoyin rigakafi su kai hari da lalata ƙwayar cuta. Duk da haka, ba duk marasa lafiya suna amsa maganin rigakafi ba, kuma ana ci gaba da bincike don gano masu nazarin halittu don hango ko wanene marasa lafiya zasu amfana. Bugu da ari, nazarin yana binciken amfani da immunotherapy a hade tare da wasu jiyya, kamar chemotherapy ko maganin da aka yi niyya, don ingantaccen inganci.

Sauran Hanyoyi masu Alkawari

Jiyya masu tasowa da Gwaje-gwajen Clinical masu Ci gaba

Bayan magungunan da aka yi niyya da maganin rigakafi, ana bincika wasu hanyoyi masu ban sha'awa maganin sabon maganin ciwon huhu na 2020. Waɗannan sun haɗa da sabon tsarin chemotherapy, ci gaban jiyya na radiation (kamar stereotactic body radiotherapy ko SBRT), da sabbin tsarin isar da magunguna. Ana gudanar da gwaje-gwaje na asibiti da yawa, ana kimanta tasirin waɗannan sabbin jiyya da kuma bincika yuwuwar haɗuwa don haɓaka sakamako. Kasancewa da sanarwa game da gwaje-gwajen asibiti da ke gudana yana da mahimmanci ga marasa lafiya da danginsu waɗanda ke neman ingantaccen zaɓin jiyya. ClinicalTrials.gov hanya ce mai mahimmanci don nemo bayanai akan gwaji na yanzu.

Makomar Maganin Ciwon daji na Huhu

Yanayin maganin cutar kansar huhu yana ci gaba da haɓakawa, tare da ci gaba da bincike da haɓakawa yana tura iyakokin abin da zai yiwu. Haɗuwa da madaidaicin magani, immunotherapy, da sauran sabbin hanyoyin dabaru suna riƙe da babban alƙawari don haɓaka sakamakon haƙuri da ƙimar rayuwa. Yana da mahimmanci ga mutanen da ke fuskantar kamuwa da cutar sankarar huhu don tuntuɓar likitan ilimin likitancin su don tattauna dabarun jiyya mafi dacewa waɗanda suka dace da takamaiman yanayin su da bayanan kwayoyin halitta. Don cikakkiyar kulawar ciwon daji, la'akari da bincika ƙwarewar da ake samu a cibiyoyi kamar su Shandong Baofa Cibiyar Nazarin Ciwon daji.

Kwatanta Bayanai: Babban Ci gaban Jiyya ()

Lura: Wannan bayanin don ilimin gabaɗaya ne da dalilai na bayanai kawai, kuma bai ƙunshi shawarar likita ba. Koyaushe tuntuɓi ƙwararren ƙwararren kiwon lafiya don kowace damuwa ta kiwon lafiya ko kafin yin kowane yanke shawara mai alaƙa da lafiyar ku ko magani.